Synthesis and Antiviral Evaluation of New N-acylhydrazones Containing Glycine Residue

Chemical Biology and Drug Design

Volumn 77, Issue 3, 2011, Pages 189-198

  Tian, Baohe ^a   He, Meizi ^a   Tan, Zhiwu ^a   Tang, Shixing ^b   Hewlett, Indira ^b   Chen, Shuguang ^a   Jin, Yinxue ^a   Yang, Ming ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Antiviral activity; HIV 1 capsid assembly; N acylhydrazone derivatives; Synthesis

Indexed keywords

2 FLUOROBENZALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; 2 FURALDEHYDE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; 2 FURALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; 3 METHOXY 4 HYDROXYBENZALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; 3,4 METHYLENEDIOXYBENZALDEHYDE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; 3,4 METHYLENEDIOXYBENZALDEHYDE N (4 TOLUENESULFONYL)TOLUENESULFONYL); 4 BROMOBENZALDEHYDE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; 4 BROMOBENZALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; 4 HYDROXYBENZALDEHYDE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; 4 METHOXYBENZALDEHYDE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; 4 METHOXYBENZALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; 4 METHYLBENZALDEHYDE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; 4 METHYLBENZALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; 4 NITROBENZALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; ACETOPHENONE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; ACETOPHENONE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; BENZALDEHYDE 2 NAPHTHYLOXYACETAMIDOACETOHYDRAZONE; BENZALDEHYDE N (4 TOLUENESULFONYL)GLYCINYL HYDRAZONE; HYDRAZONE DERIVATIVE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY TEST; DRUG SCREENING; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; BINDING SITES; CAPSID PROTEINS; CELL LINE; COMPUTER SIMULATION; GLYCINE; HIV-1; HUMANS; HYDRAZONES; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 79551710372     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2010.01050.x     Document Type: Article

References (33)

1. Cohen J. (2007) New estimates scale back scope of HIV/AIDS epidemic. Science;318:1360-1361.
2. Reeves J.D., Piefer A.J. (2005) Emerging drug targets for antiretroviral therapy. Drugs;65:1747-1766.
3. Grant R.M., Hecht F.M., Warmerdam M., Liu L., Liegler T., Petropoulos C.J., Hellmann N.S., Chesney M., Busch M.P., Kahn J.O. (2002) Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA;288:181-188.
4. Sarafianos S.G., Das K., Hughes S.H., Arnold E. (2004) Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Curr Opin Struct Biol;14:716-730.
5. Flexner C. (2007) HIV drug development: the next 25years. Nat Rev Drug Discov;6:959-966.
6. Loncle C., Brunel J.M., Vidal N., Dherbomez M., Letourneux Y. (2004) Synthesis and antifungal activity of cholesterol-hydrazone derivatives. Eur J Med Chem;39:1067-1071.
7. Fraga C.A.M., Barreiro E.J. (2006) Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs. Curr Med Chem;13:167-198.
8. Duarte C.D., Tributino J.L.M., Lacerda D.I., Martins M.V., Alexandre-Moreira M.S., Dutra F., Bechara E.J.H. et al. (2007) Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3, 4-methylenedioxyphenyl-N-acylhydrazone derivatives: discovery of LASSBio-881, a new ligand of cannabinoid receptors. Bioorg Med Chem;15:2421-2433.
9. Melnyk P., Leroux V., Sergheraert C., Grellier P. (2006) Design, synthesis and in vitro antimalarial activity of an acylhydrazone library. Bioorg Med Chem Lett;16:31-35.
10. Patole J., Sandbhor U., Padhye S., Deobagkar D.N., Anson C.E., Powell A. (2003) Structural chemistry and in vitro antitubercular activity of acetylpyridine benzoyl hydrazone and its copper complex against mycobacterium smegmatis. Bioorg Med Chem Lett;13:51-55.
11. Cunha A.C., Figueiredo J.M., Tributino J.L.M., Miranda A.L.P., Castro H.C., Zingali R.B., Fraga C.A.M., de Souza M.C.V., Ferreira V.F., Barreiro E.J. (2003) Antiplatelet properties of novel N-substituted-phenyl-1, 2, 3-triazole-4-acylhydrazone Derivatives. Bioorg Med Chem;11:2051-2059.
12. Lima L.M., Frattani F.S., dos Santos J.L., Castro H.C., Fraga C.A.M., Zingali R.B., Barreiro E.J. (2008) Synthesis and anti-platelet activity of novel arylsulfonate-acylhydrazone derivatives, designed as antithrombotic candidates. Eur J Med Chem;43:348-356.
13. Borkow G., Fletcher R.S., Barnard J., Arion D., Motakis D., Dmitrienko G.I., Parniak M.A. (1997) Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone. Biochemistry;36:3179-3185.
14. Sluis-Cremer N., Arion D., Parniak M.A. (2002) Destabilization of the HIV-1 reverse transcriptase dimer upon interaction with N-acyl hydrazone inhibitors. Mol Pharmacol;62:398-405.
15. Himmel D.M., Sarafianos S.G., Dharmasena S., Hossain M.M., McCoy-Simandle K., Ilina T., Clark A.D. Jr, Knight J.L., Julias J.G., Clark P.K., Krogh-Jespersen K., Levy R.M., Hughes S.H., Parniak M.A., Arnold E. (2006) HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel Site. ACS Chem Biol;1:702-712.
16. Peter P. Jr (2007) Small molecule inhibitors of HIV-1 capsid assembly. PCT patent WO2007048042.
17. Rossmann M.G. (1988) Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus. Proc Natl Acad Sci U S A;85:4625-4627.
18. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. (1996) Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science;273:231-235.
19. Forshey B.M., von Schwedler U., Sundquist W.I., Aiken C. (2002) Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol;76:5667-5677.
20. Lanman J., Sexton J., Sakalian M., Prevelige P.E. Jr (2002) Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro. J Virol;76:6900-6908.
21. Ganser-Pornillos B.K., Cheng A., Yeager M. (2007) Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell;131:70-79.
22. Li J., Tang S., Hewlett I., Yang M. (2007) HIV-1 capsid protein and cyclophilin A as new targets for anti-AIDS therapeutic agents. Infect Disord Drug Targets;7:238-244.
23. Tang C., Loeliger E., Kinde I., Kyere S., Mayo K., Barklis E., Sun Y., Huang M., Summers M.F. (2003) Antiviral inhibition of the HIV-1 capsid protein. J Mol Biol;327:1013-1020.
24. Kelly B.N., Kyere S., Kinde I., Tang C., Howard B.R., Robinson H., Sundquist W.I., Summers M.F., Hill C.P. (2007) Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol;373:355-366.
25. Li J., Tan Z., Tang S., Hewlett I., Pang R., He M., He S., Tian B., Chen K., Yang M. (2009) Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid. Bioorg Med Chem;17:3177-3188.
26. Tian B., He M., Tang S., Hewlett I., Tan Z., Li J., Jin Y., Yang M. (2009) Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein. Bioorg Med Chem Lett;19:2162-2167.
27. Jin Y., Tan Z., He M., Tian B., Tang S., Hewlett I., Yang M. (2010) SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA. Bioorg Med Chem;18:2135-2140.
28. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem;19:1639-1662.
29. Casaschi A., Grigg R., Sansano J.M. (2001) Palladium catalysed tandem cyclisation-anion capture. Part 7: synthesis of derivatives of α-amino esters, nitrogen heterocycles and β-aryl/heteroaryl ethylamines via in situ generated vinylstannanes. Tetrahedron;57:607-615.
30. Palaska E., Sahin G., Kelicen P., Durlu N.T., Altinok G. (2002) Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazole-3-thiones. Farmaco;57:101-107.
31. Ali I.A.I., Al-Masoudi I.A., Saeed B., Al-Masoudi N.A., Colla P.L. (2005) Amino acid derivatives, Part 2: synthesis, antiviral, and antitumor activity of simple protected amino acids functionalized at N-terminus with naphthalene side chain. Heteroat Chem;16:148-155.
32. Palla G., Predieri G., Domiano P. (1986) Conformational behaviour and E/Z isomerization of N-acyl and N-aroylhydrazones. Tetrahedron;42:3649-3654.
33. Li Y., Wang Y., Jin K., Peng Q., Liu S., Zhang Z. (2005) NMR study on 5-aryl-2-furfuraldehyde hydrazones. Chinese J Magn Reson;22:7-13.